// App-Quantinova.ai

1256-172 : SAFETY AND EFFICACY OF THE ABSORB EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD VERSUS NEW-GENERATION DURABLE POLYMER EVEROLIMUS-ELUTING STENTS: A META-ANALYSIS BASED ON CLINICAL OUTCOME DATA FROM RANDOMIZED COMPARISONS

Researchers

Presenter

  • Bertrand Njume Muketea

Principal Investigators

  • Kapil Yadava

  • Hassan Baydouna

  • Liefke C. van der Heijdena

  • Kenneth Tandjunga

  • Alvaro Alonsoa

  • Asif Anwara

  • Thierry Le Jemtela

  • Nidal Abi Rafeha

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Neoatherosclerosis

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim